Table 3.
Hazard ratios RA cohort | ||||
---|---|---|---|---|
Trend | AA vs GG | |||
Mortality | HR(95% CI) | P value | HR (95% CI) | P value |
All-cause | 1.06 (0.76-1.46) | 0.752 | 1.08 (0.54-2.15) | 0.830 |
CVD | 0.91 (0.53-1.54) | 0.713 | 0.81 (0.27-2.43) | 0.712 |
Cancer | 0.90 (0.49-1.67) | 0.741 | 0.73 (0.18-2.92) | 0.657 |
Infectious | 1.19 (0.41-3.51) | 0.748 | 1.42 (0.09-22.7) | 0.803 |
Hazards ratios non-RA cohort | ||||
Trend | GG vs AA | |||
Mortality | HR (95% CI) | P value | HR (95% CI) | P value |
All-cause | 0.99 (0.89-1.11) | 0.890 | 0.99 (0.79-1.25) | 0.924 |
CVD | 0.95 (0.80-1.12) | 0.512 | 0.89 (0.64-1.25) | 0.515 |
Cancer | 1.00 (0.82-1.21) | 0.980 | 1.02 (0.70-1.50) | 0.919 |
CI, confidence interval; HR, hazard ratio; CVD, cardiovascular disease; RA, rheumatoid arthritis.